Possible effects of melatonin on reperfusion injury following coronary artery bypass graft surgery

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 42

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-18-2_007

تاریخ نمایه سازی: 11 دی 1402

Abstract:

BACKGROUND: Although coronary artery bypass graft (CABG) surgery has been reported to be one of the most effective internentions in terms of myocardial salvage, reperfusion itself can cause additional damage to the myocardium. Since there is strong evidence that free radicals are the principal offender in ischemia-reperfusion (I/R) injury, it has been suggested that treatment with antioxidant agents can be protective. Investigations have shown that melatonin secretion is partially disturbed in CABG patients. The aim of this study was to evaluate the protective effect of melatonin as an antioxidant agent on I/R injury.METHODS: ۱۶۴ elective CABG candidates participated in this randomized clinical trial during the preoperative period. The candidates were randomized to receive ۳ mg of melatonin tablets (physiologic dose) from ۳ days before surgery until the day of discharge. Cardiac biomarkers [troponin and creatine kinase myocardial band (CKMB)] were assessed once before surgery (۲۴ hours before surgery), and ۸ and ۲۴ hours after surgery.RESULTS: Finally, ۱۳۰ patients, ۶۵ (۵۰%) patients in the melatonin group and ۶۵ (۵۰%) in the control arm finished our study. Mean age of melatonin and control groups was ۵۹.۹۰ ± ۹.۵۹ and ۶۰.۸۰ ± ۸.۰۰ years, respectively; moreover, ۴۷ (۷۲.۳۰%) in melatonin and ۴۵ (۶۹.۲۳%) in control group were men. No significant difference was seen in baseline cardiac biomarkers between two groups (P > ۰.۰۵). In both groups, cardiac biomarkers (CKMB and troponin) elevated after surgery in comparison to their preoperative values. There was no statistically significant difference between the control and melatonin groups regarding the ۸-hour and ۲۴-hour troponin and CKMB when adjusted for interacting factors (P > ۰.۰۵).CONCLUSION: Although physiological concentration of melatonin is protective against I/R injury, substitution of endogenous melatonin with the oral supplement which creates physiologic concentration may not prevent I/R injury. In order to have antioxidant effect, pharmacologic doses of melatonin should be employed.

Keywords:

Melatonin , Coronary Artery Bypass Graft Surgery , Ischemia Reperfusion Injury

Authors

Azita Hajhossein-Talasaz

Professor, Department of Clinical Pharmacy, School of Pharmacy AND Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Mehrnoush Dianatkhah

Fellowship of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy AND Cardiac Rehabilitation Research Center, Cardiovascular Research Institute,, Isfahan University of Medical Sciences, Isfahan, Iran

Abbass Salehiomran

Professor, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Padideh Ghaeli

Professor, Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Minoo Dianatkhah

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, ...
  • Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, ...
  • Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium ...
  • Piper HM, Garcia-Dorado D, Ovize M. A fresh look at ...
  • Chandrasena LG, Peiris H, Waikar HD. Biochemical changes associated with ...
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC, Reiter RJ, ...
  • Yin YQ, Luo AL, Guo XY, Li LH, Huang YG. ...
  • Altun A, Ugur-Altun B. Melatonin: Therapeutic and clinical utilization. Int ...
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Reiter RJ. Prognostic value ...
  • Dominguez-Rodriguez A, Abreu-Gonzalez P. Myocardial ischemia-reperfusion injury: Possible role of ...
  • Petrosillo G, Di VN, Pistolese M, Casanova G, Tiravanti E, ...
  • Dianatkhah M, Najafi A, Sharifzadeh M, Ahmadi A, Sharifnia H, ...
  • Sokullu O, Sanioglu S, Kurc E, Sargin M, Deniz H, ...
  • Zhang Y, Wang Y, Xu J, Tian F, Hu S, ...
  • Dianatkhah M, Ghaeli P, Hajhossein TA, Karimi A, Salehiomran A, ...
  • Guo XY, Luo AL, Ren HZ, Yie TH, Huang YG. ...
  • Yoshitaka S, Egi M, Morimatsu H, Kanazawa T, Toda Y, ...
  • Yin YQ, Luo AL, Guo XY, Li LH, Ren HZ, ...
  • Zhou H, Ma Q, Zhu P, Ren J, Reiter RJ, ...
  • Bourne RS, Mills GH. Melatonin: Possible implications for the postoperative ...
  • Mistraletti G, Sabbatini G, Taverna M, Figini MA, Umbrello M, ...
  • Gogenur I, Kucukakin B, Panduro JL, Reiter RJ, Rosenberg J. ...
  • Haghjooy JS, Ziaei A, Ziaei S, Ziaei E, Mirmohammad-Sadeghi M. ...
  • Reiter RJ, Tan DX. Melatonin: A novel protective agent against ...
  • Gitto E, Romeo C, Reiter RJ, Impellizzeri P, Pesce S, ...
  • Vural EM, van Munster BC, de Rooij SE. Optimal dosages ...
  • نمایش کامل مراجع